Key Takeaways (Summary): The Proposal: The FDA is moving to remove three major GLP-1 drugs from the 503B bulks list, which would prevent outsourcing facilities from compounding them using bulk substances
doi: 10.1210/endo.131.3.1324152
Effects of glucose and lactate on Streptococcus mutans abundance in a novel multispecies oral biofilm model
It's time to clean the injection site
Injection site reactions, including bruising, are documented adverse effects in semaglutide clinical trials, though bruising is not separately reported in FDA labeling
Avoid high-fat foods, citrus, chocolate, and spicy dishes at least 3 hours before bedtime, as these trigger acid secretion and impair the sphincter's ability to seal